E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
SGMOQ holding history
Sangamo Therapeutics, Inc in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SGMOQ overviewAll 13F holders of SGMOQFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −24,853−100.0% | Sold out | Holders |
| Q4 2024 | 24,853 | $25.4K | <0.1% | +24,853 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −35,003−100.0% | Sold out | Holders |
| Q1 2023 | 35,003 | $62.0K | <0.1% | −2,004−5.4% | Reduced | Holders |
| Q4 2022 | 37,007 | $116.0K | <0.1% | +9,284+33.5% | Added | Holders |
| Q3 2022 | 27,723 | $136.0K | <0.1% | −3,869−12.2% | Reduced | Holders |
| Q2 2022 | 31,592 | $131.0K | <0.1% | +8,491+36.8% | Added | Holders |
| Q1 2022 | 23,101 | $134.0K | <0.1% | +11,383+97.1% | Added | Holders |
| Q4 2021 | 11,718 | $88.0K | <0.1% | +672+6.1% | Added | Holders |
| Q3 2021 | 11,046 | $100.0K | <0.1% | – | No prior filing | Holders |
| Q2 2021 | – | – | – | – | Not filed | Holders |
| Q1 2021 | 12,015 | $151.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.